Gabel C A, Kornfeld S
J Cell Biol. 1984 Jul;99(1 Pt 1):296-305. doi: 10.1083/jcb.99.1.296.
The murine plasma cell line MOPC 315 efficiently targets newly synthesized acid hydrolases to lysosomes in spite of a marked deficiency in the level of the mannose 6-phosphate receptor (Gabel, C., D. Goldberg, and S. Kornfeld, 1983, Proc. Natl. Acad. Sci. USA, 80:775-779). To better understand the routing of lysosomal enzymes in this cell line, pulse-chase experiments were performed with [2-3H]mannose and [35S]methionine followed by immunoprecipitation of beta-glucuronidase and IgA. By 3 h of chase, essentially all of the newly synthesized beta-glucuronidase had undergone proteolytic processing, suggesting that the molecules had reached lysosomes. At this time 30% of the pulse-labeled IgA was still intracellular. The oligosaccharides on the intracellular IgA were of the high mannose-type, while the secreted IgA contained processed, complex-type oligosaccharides. This indicates that the intracellular IgA was still in the endoplasmic reticulum or an early region of the Golgi complex when all of the beta-glucuronidase had reached lysosomes. Therefore, beta-glucuronidase and IgA must exit from the endoplasmic reticulum or the early Golgi complex at different rates, a finding that is inconsistent with bulk phase movement of these proteins from the endoplasmic reticulum to the trans Golgi complex. The addition of the ionophore monensin greatly slows the rate of IgA secretion from MOPC 315 cells and the molecules secreted have incompletely processed oligosaccharides. In contrast, monensin only slightly delays the transport of newly synthesized beta-glucuronidase to lysosomes and causes no significant alteration in the extent of oligosaccharide phosphorylation, a process that appears to occur in the early (cis) Golgi complex. However, the labeled beta-glucuronidase was deficient in sialylated, phosphorylated hybrid oligosaccharides whose biosynthesis requires the action of late stage oligosaccharide processing enzymes assumed to be localized in the trans Golgi complex.
小鼠浆细胞系MOPC 315能有效地将新合成的酸性水解酶靶向溶酶体,尽管其甘露糖6 - 磷酸受体水平明显不足(加贝尔,C.,D. 戈德堡,和S. 科恩菲尔德,1983年,《美国国家科学院院刊》,80:775 - 779)。为了更好地理解该细胞系中溶酶体酶的转运途径,用[2 - 3H]甘露糖和[35S]甲硫氨酸进行脉冲追踪实验,随后对β - 葡萄糖醛酸酶和IgA进行免疫沉淀。追踪3小时后,基本上所有新合成的β - 葡萄糖醛酸酶都经历了蛋白水解加工,这表明这些分子已到达溶酶体。此时,30%的脉冲标记IgA仍在细胞内。细胞内IgA上的寡糖是高甘露糖型,而分泌的IgA含有加工后的复合型寡糖。这表明当所有β - 葡萄糖醛酸酶都到达溶酶体时,细胞内IgA仍在内质网或高尔基体复合体的早期区域。因此,β - 葡萄糖醛酸酶和IgA必须以不同的速率从内质网或早期高尔基体复合体中排出,这一发现与这些蛋白质从内质网到反式高尔基体复合体的批量转运不一致。离子载体莫能菌素的添加极大地减慢了IgA从MOPC 315细胞分泌的速率,且分泌的分子具有未完全加工的寡糖。相比之下,莫能菌素仅略微延迟新合成的β - 葡萄糖醛酸酶向溶酶体的转运,并且在寡糖磷酸化程度上没有引起显著改变,寡糖磷酸化过程似乎发生在早期(顺式)高尔基体复合体中。然而,标记的β - 葡萄糖醛酸酶缺乏唾液酸化、磷酸化的杂合寡糖,其生物合成需要假定位于反式高尔基体复合体中的晚期寡糖加工酶的作用。